[PDF][PDF] Large-scale in-house cell-based assay for evaluating the serostatus in patients with neuromyelitis optica spectrum disorder based on new diagnostic criteria
Y Kim, G Kim, BS Kong, JE Lee… - Journal of Clinical …, 2017 - synapse.koreamed.org
Background and Purpose The detection of aquaporin 4-IgG (AQP4-IgG) is now a critical
diagnostic criterion for neuromyelitis optica spectrum disorder (NMOSD). To evaluate the …
diagnostic criterion for neuromyelitis optica spectrum disorder (NMOSD). To evaluate the …
Repeated follow-up of AQP4-IgG titer by cell-based assay in neuromyelitis optica spectrum disorders (NMOSD)
T Akaishi, T Takahashi, I Nakashima, M Abe… - Journal of the …, 2020 - Elsevier
Introduction Neuromyelitis optica spectrum disorder (NMOSD) is characterized by the
presence of serum anti-aquaporin 4 (AQP4) antibody. However, the significance of changes …
presence of serum anti-aquaporin 4 (AQP4) antibody. However, the significance of changes …
Diagnostic value of aquaporin-4-IgG live cell based assay in neuromyelitis optica spectrum disorders
V Redenbaugh, M Montalvo, E Sechi… - Multiple Sclerosis …, 2021 - journals.sagepub.com
Objective Determine the utility of aquaporin 4 IgG (AQP4-IgG) testing (live cell-based assay)
for Neuromyelitis Optica Spectrum Disorders (NMOSD). Methods We included Mayo Clinic …
for Neuromyelitis Optica Spectrum Disorders (NMOSD). Methods We included Mayo Clinic …
[HTML][HTML] Anti-aquaporin 4 IgG is not associated with any clinical disease characteristics in neuromyelitis optica spectrum disorder
O Schmetzer, E Lakin, B Roediger, A Duchow… - Frontiers in …, 2021 - frontiersin.org
Background: Neuromyelitis optica spectrum disorder (NMOSD) is a clinically defined,
inflammatory central nervous system (CNS) disease of unknown cause, associated with …
inflammatory central nervous system (CNS) disease of unknown cause, associated with …
Overcoming the challenges in diagnosis of AQP4-IgG positive neuromyelitis optica spectrum disorders in resource poor settings using an indigenized and cost …
Background Diagnosis of neuromyelitis optica spectrum disorders (NMOSD) in India is
hindered by limited access to cost effective and sensitive assays for detection of aquaporin-4 …
hindered by limited access to cost effective and sensitive assays for detection of aquaporin-4 …
Rapid immunodot AQP4 assay for neuromyelitis optica spectrum disorder
Y Fu, J Bi, Y Yan, X Sun, K Li, SY Kim, SM Han… - JAMA …, 2023 - jamanetwork.com
Importance Immunoglobulin G autoantibodies for aquaporin 4 (AQP4-IgG) serve as
diagnostic biomarkers for neuromyelitis optica spectrum disorder (NMOSD), and the most …
diagnostic biomarkers for neuromyelitis optica spectrum disorder (NMOSD), and the most …
Factors associated with the misdiagnosis of neuromyelitis optica spectrum disorder
AD Smith, TM Moog, KW Burgess, M McCreary… - Multiple Sclerosis and …, 2023 - Elsevier
Background Neuromyelitis optica spectrum disorder (NMOSD) is a rare autoimmune
condition that is associated with severe disability. Approximately 40% of individuals are …
condition that is associated with severe disability. Approximately 40% of individuals are …
Anti-aquaporin-4 titer is not predictive of disease course in neuromyelitis optica spectrum disorder: a multicenter cohort study
RA Kessler, MA Mealy, JA Jimenez-Arango… - Multiple sclerosis and …, 2017 - Elsevier
Background Neuromyelitis optica spectrum disorder (NMOSD) is a rare autoimmune
disease associated with a serological antibody to aquaporin-4 (AQP4) detectable in up to …
disease associated with a serological antibody to aquaporin-4 (AQP4) detectable in up to …
[PDF][PDF] Neuromyelitis optica spectrum disorders with and without aquaporin 4 antibody: Characterization, differential diagnosis, and recent advances
RJ Baranello, JR Avasarala - J Neuro Ther, 2015 - nobleresearch.org
Importance: The term neuromyelitis optica spectrum disorders (NMOSD) currently includes
neuromyelitis optica (NMO) and rare neurological disorders characterized by specific IgG …
neuromyelitis optica (NMO) and rare neurological disorders characterized by specific IgG …
Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica
Y Jiao, JP Fryer, VA Lennon, SM Jenkins, AML Quek… - Neurology, 2013 - AAN Enterprises
Objective: To 1) determine, using contemporary recombinant antigen–based assays, the
aquaporin-4 (AQP4)–immunoglobulin G (IgG) detection rate in sequential sera of patients …
aquaporin-4 (AQP4)–immunoglobulin G (IgG) detection rate in sequential sera of patients …